EcoDrugPlus

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSLCAG00010010858
Gene Symbol: GRM3
4 Cross references
215 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSLCAG00010025959
Gene Symbol: GRM5A
1 Cross references
211 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSLCAG00010021672
Gene Symbol: GRM5B
1 Cross references
216 Possible Orthologues:

Glutaminase B

Ensembl ID : ENSLCAG00010000783
Gene Symbol: GLSB
3 Cross references
230 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial

Ensembl ID : ENSLCAG00010013844
Gene Symbol: LOC108873076
4 Cross references
228 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSLCAG00010000124
Gene Symbol: GSK3AB
4 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate A

Ensembl ID : ENSLCAG00010027248
Gene Symbol: GSK3BA
4 Cross references
222 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta

Ensembl ID : ENSLCAG00010022146
Gene Symbol: LOC108881923
4 Cross references
187 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor

Ensembl ID : ENSLCAG00010007487
Gene Symbol: LOC108896210
4 Cross references
135 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSLCAG00010011673
Gene Symbol: LOC127138922
3 Cross references
155 Possible Orthologues:

Granzyme B-Like

Ensembl ID : ENSLCAG00010002973
Gene Symbol: LOC108877301
3 Cross references
960 Possible Orthologues:

Granzyme B-Like

Ensembl ID : ENSLCAG00010002086
Gene Symbol: LOC108895425
3 Cross references
960 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).